ARTICLE | Company News
Biovail receives tentative approval
July 25, 2000 7:00 AM UTC
The FDA granted BVF tentative approval of its once daily controlled release version of Procardia XL nifedipine, which is marketed by Pfizer (PFE) to treat hypertension and angina. BVF will market the ...